Post-Approval Insights: Adverse Events of AMD Treatments – Pegcetacoplan, Faricimab, & Brolucizumab

Описание: Understanding Adverse Events in AMD Treatments: Pegcetacoplan, Faricimab, and Brolocizumab

Overview:
What could have gone wrong with the clinical trials? Dr. Neofytos Mavris invites you to delve into the complexities of managing Age-related Macular Degeneration (AMD).

Session Details:
In this educational session, Dr. Mavris goes beyond presenting information; he challenges viewers to think critically. The lecture begins with examining real-world case reports that vividly illustrate the practical impacts of AMD and PCV treatments. It transitions into a comprehensive overview of AMD, discussing the condition's significance and the necessity for effective treatment strategies.

At the core of the lecture, Dr. Mavris focuses on three significant medications: Pegcetacoplan, Faricimab, and Brolocizumab. He details the clinical trials that led to their FDA approval and explores the subsequent adverse events reported. By the end of this video, Dr. Mavris provokes questions about the efficacy and safety of these treatments, encouraging viewers to consider potential research gaps and what might have been overlooked in these studies.

Audience:
This lecture is tailored for healthcare professionals, ophthalmology students, and anyone interested in the development and implications of treatments for Age-related Macular Degeneration.

🔔 Subscribe for more insightful medical presentations and tips on eye health. Drop your questions or experiences in the comments below—we love hearing from you!

About Dr. Neofytos Mavris:
Dr. Neofytos Mavris is a dedicated medical professional specializing in Ophthalmology. A proud graduate of Comenius University in Bratislava, Dr. Mavris excelled in his studies and pursued further excellence by taking the USMLE. His ambition and passion for ophthalmology led him to one of the world's prestigious institutions, the Hadassah Medical Center in Israel, where he is currently deepening his expertise and contributing to the field.

Timestamps:
00:00 - INTRO
02:43 - AMD
05:20 - PEGCETACOPLAN
11:00 - BROLOCIZUMAB
13:55 - FARICIMAB
16:47 - DISCUSSION

#amd #eyehealth #ophthalmology
---------------------------------------------------------------------------------------------
Disclaimer:
The opinions and views expressed in this video are those of Dr. Neofytos Mavris. They reflect his current understanding and expertise in the field of ophthalmology. Dr. Mavris reserves the right to update and evolve his knowledge and viewpoints over time without prior notice. This can result in changes to his stance on certain topics discussed herein. This channel includes links to external websites managed by third parties. These links are provided solely for your convenience and informational purposes. Dr. Mavris is not responsible for the content, products, or services offered by external sites.